In Abrupt Reversal, FDA Yanks Ixchiq Vaccine Over Safety Concern

(MedPage Today) — Just 2 weeks after lifting a pause on the use of the chikungunya live-attenuated vaccine (Ixchiq) in people 60 years and older, the FDA suspended the vaccine’s license entirely over “serious” safety concerns.
The Center for…